王云
DOI:10.16662/j.cnki.1674-0742.2017.23.124
[摘要] 目的 探讨氧驱雾化吸入普米克令舒治疗小儿哮喘急性发作的临床疗效。方法 从该院于2015年4月—2017年2月就诊的儿科患者中,随机选取60例急性哮喘就诊的患儿作为研究对象,随机分为2组,每组30例患者。常规组给予常规治疗,研究组给予氧驱雾化吸入普米克令舒治疗。对比两组患者血气指标、肺功能、治疗疗效及不良反应的情况。结果 研究组FVC、FEV1、FEV1/ FVC改善情况均优于常规组;研究组治疗总有效率96.67%显著高于常规组76.67%;研究组不良反应总发生率6.67%显著低于常规组23.33%;差异有统计学意义(P<0.05)。结论 小儿急性哮喘采用氧驱雾化吸入普米克令舒治疗可提高治疗疗效,改善患儿肺功能,且安全可靠。
[关键词] 小儿哮喘;氧驱雾化吸入普米克令舒;肺功能
[中图分类号] R5 [文献标识码] A [文章编号] 1674-0742(2017)08(b)-0124-03
Clinical Efficacy of Oxygen Atomized Inhalation of Pulmicort in the Treatment of Acute Exacerbations of Asthma in Children
WANG Yun
Department of Pediatrics, Liyang Maternal and Child Health Hospital, Changzhou, Jiangsu Province, 213300 China
[Abstracts] Objective This paper tries to explore the clinical effect of oxygen atomized inhalation of Pulmicort in the treatment of acute exacerbations of asthma in children. Methods 60 cases of acute asthma patients from April 2015 to February 2017 in this hospital were random selected and randomly divided into two groups, with 30 patients in each group. The routine group was given routine treatment; the study group was given oxygen atomized inhalation of pulmicort treatment. The blood gas index, lung function, therapeutic efficacy and adverse reactions were compared between the two groups. Results The improvement of FVC、FEV1、FEV1/ FVC in the study group was better than the conventional group; the total effective rate was 96.67% in the study group, significantly higher than that of the conventional group of 76.67%; the total incidence of adverse effects was 6.67% in the study group, significantly lower than the conventional group of 23.33%; the differences were statistically significant (P<0.05). Conclusion The oxygen atomized inhalation of pulmicort treatment for acute asthma in children can improve curative effect and pulmonary function, which is safe and reliable.
[Key words] Infantile asthma; Oxygen atomized inhalation of pulmicort; Lung function
近年来,小儿哮喘的发病率呈现逐渐上升,以呼吸困难、反复咳嗽伴气喘为主要表现,具有气道高反应性。小儿哮喘病程较长,若不及时就诊,可发展严重肺炎,对患儿生长发育造成极大影响[1-3]。结合小儿机体各方面发育均未完善,其身体免疫力较低,用药易发生不良反应发生。目前小儿哮喘治疗越来越受到重视,目前临床研发治疗小儿哮喘药物种类越来越多,其治疗主要以快速见效,降低不良反应发生率为主要治疗目标,故临床进行小儿哮喘治疗需选择适合患儿的药物。普米克令舒是小儿哮喘的预防及治疗药物,疗效较好,具有抗炎、减少气道渗出、消除气道水肿的作用。……